BNIGF
Beroni Group Ltd.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 27 |
Stock Information
Note: Financial values converted from AUD to USD
| Shares Outstanding | 28.12M |
| Total Debt | $1.33M |
| Cash Equivalents | $354K |
| Revenue | $454K |
| Net Income | $-3.00M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $180K |
| EPS (TTM) | $-0.20 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.26M |
| Sales | $454K |
| Income | $-3.00M |
| Book/sh | $0.11 |
| Cash/sh | $0.02 |
Financial Ratios
| Quick Ratio | 0.59 |
| Current Ratio | 1.25 |
| Debt/Eq | 38.51 |
Returns & Margins
| ROA | -36.43% |
| ROE | -101.49% |
| Gross Margin | 75.17% |
| Operating Margin | 1501.58% |
Ownership
| Insider Ownership | 73.93% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.28 |
| P/B | 0.06 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.01 |
| RSI | nan |
| Shares Float | 13.20M |
| Volatility | -1.87 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| 6 Months | +0.00% |
| YTD | +0.00% |
| Year | -36.63% |
| 3 Years | -99.94% |
| 5 Years | -99.93% |
| 10 Years | -99.91% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.01 | 0 |
| 2026-06-03 | $0.01 | 0 |
| 2026-06-02 | $0.01 | 0 |
| 2026-06-01 | $0.01 | 0 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 0 |
| 2026-05-27 | $0.01 | 0 |
| 2026-05-26 | $0.01 | 0 |
| 2026-05-22 | $0.01 | 0 |
| 2026-05-21 | $0.01 | 0 |
| 2026-05-20 | $0.01 | 0 |
| 2026-05-19 | $0.01 | 0 |
| 2026-05-18 | $0.01 | 0 |
| 2026-05-15 | $0.01 | 0 |
| 2026-05-14 | $0.01 | 0 |
| 2026-05-13 | $0.01 | 0 |
| 2026-05-12 | $0.01 | 0 |
| 2026-05-11 | $0.01 | 0 |
| 2026-05-08 | $0.01 | 0 |
| 2026-05-07 | $0.01 | 0 |
| 2026-05-06 | $0.01 | 0 |
| 2026-05-05 | $0.01 | 0 |
About Beroni Group Ltd.
Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics, and viral diagnostic kits in China. It operates through four segments: Cell Therapies; Developing New Anti-Cancer Drugs; E-commerce Platform for Pharmaceutical and Healthcare Products; and Detection & Diagnosis of Infectious Diseases. The company offers NicoBloc, a smoking cessation/harm reduction product; SARS-CoV-2 IgG/IgM antibody detection kit; COVID-19 Antigen Rapid Test Kit; Bei Feiqing Tablet Candy, Bei Jingli Tablet Candy, and Beilemei freeze-dried powder; and cosmetic products, such as V show rejuvenation liquid, hyaluronic acid moisturizing silk mask, and avocado poly-peptide intensive treatment silk mask. It also provides CII-ArboViroPlex rRT-PCR assay that detects zika, dengue, chikungunya, and west nile viruses; stem cell cosmetics products comprising AGG Skin-Smoothing and Anti-Wrinkle Facial Mask, AGG Skin-Smoothing and Anti-Wrinkle Sample Pack, ODd Skin Repair Essence, AGG Skin-Smoothing and Anti-Wrinkle Essence, and ODd Beroni Beauty Facial Mask; and cardiology, hepatology, and oncology and immunotherapy solutions. In addition, the company offers cell therapies for cancer treatment; research on the treatment of cancer, as well as development of targeted therapies, immunotherapies, cancer vaccines, chemotherapy, radiation therapy, and surgery; and provides e-commerce platform for pharmaceutical and healthcare products. Further, it provides fogibloc air purifier and olansi water filter products. Beroni Group Limited was founded in 2014 and is headquartered in Sydney, Australia.
đ° Latest News
No news articles available at the moment. Check back later for updates on BNIGF.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $535,553 | $310,921 | $400,309 |
| Cost Of Revenue | $535,553 | $310,921 | $400,309 |
| Total Revenue | $468,730 | $638,916 | $2,196,766 |
| Operating Revenue | $468,730 | $638,916 | $2,196,766 |
| Expenses | |||
| Interest Expense | $322,671 | $64,014 | $39,783 |
| Total Expenses | $6,093,962 | $8,798,493 | $5,391,180 |
| Other Income Expense | $-3,566,358 | $-188,190 | $386,811 |
| Net Non Operating Interest Income Expense | $-264,750 | $96,267 | $-32,528 |
| Interest Expense Non Operating | $322,671 | $64,014 | $39,783 |
| Operating Expense | $5,558,409 | $8,487,572 | $4,990,871 |
| Other Operating Expenses | $-252,167 | $-298,528 | $-463,358 |
| Selling And Marketing Expense | $451,508 | $478,614 | $359,495 |
| General And Administrative Expense | $5,359,068 | $8,307,486 | $5,094,734 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-9,227,128 | $-8,069,714 | $-2,663,302 |
| Net Interest Income | $-264,750 | $96,267 | $-32,528 |
| Interest Income | $57,921 | $160,281 | $7,255 |
| Normalized Income | $-6,552,360 | $-7,928,572 | $-2,953,410 |
| Net Income From Continuing And Discontinued Operation | $-9,227,128 | $-8,069,714 | $-2,663,302 |
| Net Income Common Stockholders | $-9,227,128 | $-8,069,714 | $-2,663,302 |
| Net Income | $-9,227,128 | $-8,069,714 | $-2,663,302 |
| Net Income Including Noncontrolling Interests | $-9,457,091 | $-8,252,269 | $-2,882,951 |
| Net Income Continuous Operations | $-9,457,091 | $-8,252,269 | $-2,882,951 |
| Pretax Income | $-9,456,340 | $-8,251,500 | $-2,840,131 |
| Special Income Charges | $-981,368 | $-54,123 | $507,753 |
| Interest Income Non Operating | $57,921 | $160,281 | $7,255 |
| Operating Income | $-5,625,232 | $-8,159,577 | $-3,194,414 |
| Gross Profit | $-66,823 | $327,995 | $1,796,457 |
| Net Income Discontinuous Operations | - | - | $0 |
| Earnings From Equity Interest | - | - | $0 |
| Per Share | |||
| Diluted EPS | $-0.47 | $-0.42 | $-0.14 |
| Basic EPS | $-0.47 | $-0.42 | $-0.14 |
| Other | |||
| Tax Effect Of Unusual Items | $-891,590 | $-47,048 | $96,703 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-5,567,311 | $-7,999,296 | $-3,187,159 |
| Total Unusual Items | $-3,566,358 | $-188,190 | $386,811 |
| Total Unusual Items Excluding Goodwill | $-3,566,358 | $-188,190 | $386,811 |
| EBITDA (Bullshit earnings) | $-9,133,669 | $-8,187,486 | $-2,800,348 |
| EBIT | $-9,133,669 | $-8,187,486 | $-2,800,348 |
| Diluted Average Shares | $19,735,520 | $19,158,771 | $18,949,358 |
| Basic Average Shares | $19,735,520 | $19,158,771 | $18,949,358 |
| Diluted NI Availto Com Stockholders | $-9,227,128 | $-8,069,714 | $-2,663,302 |
| Minority Interests | $229,963 | $182,555 | $219,649 |
| Tax Provision | $751 | $769 | $42,820 |
| Write Off | $981,368 | $54,123 | $-507,753 |
| Gain On Sale Of Security | $-2,584,990 | $-134,067 | $-120,942 |
| Selling General And Administration | $5,810,576 | $8,786,100 | $5,454,229 |
| Other Gand A | $5,359,068 | $8,307,486 | $5,094,734 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-3,346,064 | $3,934,581 | $4,358,985 |
| Total Assets | $10,075,625 | $10,420,118 | $11,817,298 |
| Total Non Current Assets | $4,446,423 | $5,203,791 | $3,753,987 |
| Goodwill And Other Intangible Assets | $3,184,867 | $3,255,878 | $3,319,152 |
| Other Intangible Assets | $3,184,867 | $3,255,878 | $3,252,777 |
| Current Assets | $5,629,202 | $5,216,327 | $8,063,311 |
| Other Current Assets | $876,345 | $600,089 | $477,844 |
| Inventory | $104,051 | $293,720 | $316,072 |
| Receivables | $612,550 | $1,744,912 | $1,524,438 |
| Other Receivables | $209,793 | $373,867 | $391,813 |
| Taxes Receivable | $75,925 | $42,582 | $0 |
| Accounts Receivable | $326,832 | $1,328,463 | $1,132,625 |
| Allowance For Doubtful Accounts Receivable | $-2,747,517 | $-1,839,365 | $-1,873,674 |
| Gross Accounts Receivable | $3,074,349 | $3,167,828 | $3,164,760 |
| Cash Cash Equivalents And Short Term Investments | $4,036,256 | $2,577,606 | $5,744,957 |
| Cash And Cash Equivalents | $4,036,256 | $2,577,606 | $5,744,957 |
| Cash Financial | $4,036,256 | $2,577,606 | $5,744,957 |
| Other Non Current Assets | - | $50,197 | $51,165 |
| Prepaid Assets | - | - | $477,844 |
| Debt | |||
| Net Debt | $256,761 | - | - |
| Total Debt | $4,851,929 | $1,503,630 | $3,148,198 |
| Long Term Debt And Capital Lease Obligation | $485,447 | $515,239 | $34,260 |
| Long Term Debt | $138,260 | - | - |
| Current Debt And Capital Lease Obligation | $4,366,482 | $988,391 | $3,113,938 |
| Current Debt | $4,154,757 | $725,795 | $2,884,565 |
| Other Current Borrowings | $4,154,757 | $725,795 | $2,884,565 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $10,075,839 | $2,841,703 | $3,602,435 |
| Total Non Current Liabilities Net Minority Interest | $501,730 | $515,239 | $34,260 |
| Derivative Product Liabilities | $16,283 | $0 | $0 |
| Current Liabilities | $9,574,109 | $2,326,464 | $3,568,175 |
| Other Current Liabilities | $4,823,820 | $750,111 | $345,982 |
| Payables And Accrued Expenses | $383,807 | $587,962 | $108,255 |
| Payables | $383,807 | $587,962 | $108,255 |
| Total Tax Payable | $0 | $0 | $86,657 |
| Accounts Payable | $383,807 | $587,962 | $21,598 |
| Equity | |||
| Common Stock Equity | $-161,197 | $7,190,459 | $7,678,137 |
| Total Equity Gross Minority Interest | $-214 | $7,578,415 | $8,214,863 |
| Stockholders Equity | $-161,197 | $7,190,459 | $7,678,137 |
| Other Equity Interest | $3,010,038 | $3,010,038 | - |
| Gains Losses Not Affecting Retained Earnings | $6,540,146 | $4,052,996 | $-610,373 |
| Retained Earnings | $-42,264,068 | $-30,528,577 | $-22,347,492 |
| Long Term Equity Investment | $0 | $0 | $0 |
| Investments In Other Ventures Under Equity Method | $0 | $0 | $0 |
| Other | |||
| Ordinary Shares Number | $20,013,441 | $19,159,593 | $19,154,593 |
| Share Issued | $20,013,441 | $19,159,593 | $19,154,593 |
| Tangible Book Value | $-3,346,064 | $3,934,581 | $4,358,985 |
| Invested Capital | $4,131,820 | $7,916,254 | $10,562,702 |
| Working Capital | $-3,944,907 | $2,889,863 | $4,495,136 |
| Capital Lease Obligations | $558,912 | $777,835 | $263,633 |
| Total Capitalization | $-22,937 | $7,190,459 | $7,678,137 |
| Minority Interest | $160,983 | $387,956 | $536,726 |
| Capital Stock | $32,552,687 | $30,656,002 | $30,636,002 |
| Common Stock | $32,552,687 | $30,656,002 | $30,636,002 |
| Long Term Capital Lease Obligation | $347,187 | $515,239 | $34,260 |
| Current Capital Lease Obligation | $211,725 | $262,596 | $229,373 |
| Investments And Advances | $0 | $0 | $0 |
| Net PPE | $1,261,556 | $1,897,716 | $383,670 |
| Accumulated Depreciation | $-1,156,514 | $-1,425,793 | $-589,735 |
| Gross PPE | $2,418,070 | $3,323,509 | $383,670 |
| Leases | $1,559,336 | $2,463,450 | $808,556 |
| Other Properties | $326,858 | $326,858 | $383,670 |
| Machinery Furniture Equipment | $531,876 | $533,201 | $138,964 |
| Properties | $0 | $0 | $0 |
| Finished Goods | $102,112 | $291,006 | $311,970 |
| Raw Materials | $1,939 | $2,714 | $4,102 |
| Land And Improvements | - | $882,459 | $0 |
| Duefrom Related Parties Current | - | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-2,718,129 | $-3,545,382 | $-2,019,094 |
| Operating Activities | |||
| Cash Flowsfromusedin Operating Activities Direct | $-2,713,081 | $-2,678,878 | $-2,001,099 |
| Classesof Cash Receiptsfrom Operating Activities | $952,744 | $1,000,893 | $2,933,062 |
| Investing Activities | |||
| Capital Expenditure | $-5,048 | $-866,504 | $-17,995 |
| Investing Cash Flow | $29,743 | $-861,724 | $-15,238 |
| Cash Flow From Continuing Investing Activities | $29,743 | $-861,724 | $-15,238 |
| Financing Activities | |||
| Financing Cash Flow | $4,193,893 | $441,518 | $2,771,122 |
| Cash Flow From Continuing Financing Activities | $4,193,893 | $441,518 | $2,771,122 |
| Issuance Of Capital Stock | - | $0 | $2,470,000 |
| Net Common Stock Issuance | - | $0 | $2,470,000 |
| Common Stock Issuance | - | $0 | $2,470,000 |
| Other | |||
| Repayment Of Debt | $-217,466 | $-243,650 | $-224,540 |
| Issuance Of Debt | $4,411,359 | $685,168 | $525,662 |
| End Cash Position | $4,036,256 | $2,577,606 | $5,744,957 |
| Beginning Cash Position | $2,577,606 | $5,744,957 | $4,768,763 |
| Effect Of Exchange Rate Changes | $-51,905 | $-68,267 | $221,410 |
| Changes In Cash | $1,510,555 | $-3,099,084 | $754,784 |
| Net Issuance Payments Of Debt | $4,193,893 | $441,518 | $301,122 |
| Net Long Term Debt Issuance | $4,193,893 | $441,518 | $-217,545 |
| Long Term Debt Payments | $-217,466 | $-243,650 | $-217,545 |
| Long Term Debt Issuance | $4,411,359 | $685,168 | $525,662 |
| Interest Received Cfi | $18,742 | $4,780 | $292 |
| Net Intangibles Purchase And Sale | $0 | $-8,676 | $-12,345 |
| Purchase Of Intangibles | $0 | $-8,676 | $-12,345 |
| Net PPE Purchase And Sale | $11,001 | $-857,828 | $-3,185 |
| Sale Of PPE | $16,049 | $0 | $2,465 |
| Purchase Of PPE | $-5,048 | $-857,828 | $-5,650 |
| Taxes Refund Paid Direct | $-157,410 | $-178,274 | $-217,557 |
| Interest Paid Direct | $-59,091 | $-31,637 | $-33,011 |
| Classesof Cash Payments | $-3,606,734 | $-3,648,134 | $-4,901,150 |
| Paymentsto Suppliersfor Goodsand Services | $-3,449,324 | $-3,469,860 | $-4,683,593 |
| Receiptsfrom Government Grants | $309,181 | $375,820 | - |
| Receiptsfrom Customers | $643,563 | $625,073 | $2,933,062 |
| Net Short Term Debt Issuance | - | $-56,378 | $518,667 |
| Short Term Debt Payments | - | $-70,774 | $-6,995 |
| Short Term Debt Issuance | - | $14,396 | $525,662 |
| Net Investment Purchase And Sale | - | $0 | $0 |
| Purchase Of Investment | - | $0 | $0 |
| Net Business Purchase And Sale | - | - | $0 |
| Purchase Of Business | - | - | $0 |
Fetched: 2026-02-02